United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 11, 2026 · Filed Jun 12, 2026

On Jun 11, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$549.23 for US$5.22M under a trading plan, leaving 40,513 shares. Filed Jun 12, 2026 (Form 4).

Sold
9,500 shares
Price
US$549.23 average (US$542.98 to US$551.87)
Value
US$5.22M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 11, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 11, 2026Common StockSale82US$542.9849,931Direct
Jun 11, 2026Common StockSale51US$543.6149,880Direct
Jun 11, 2026Common StockSale576US$545.0049,304Direct
Jun 11, 2026Common StockSale31US$545.5549,273Direct
Jun 11, 2026Common StockSale159US$547.2549,114Direct
Jun 11, 2026Common StockSale2,006US$548.0947,108Direct
Jun 11, 2026Common StockSale1,936US$549.2145,172Direct
Jun 11, 2026Common StockSale2,939US$550.0742,233Direct
Jun 11, 2026Common StockSale1,400US$551.1540,833Direct
Jun 11, 2026Common StockSale320US$551.8740,513Direct

Source

View original at SEC

Related